Abstract:Despite substantial progress being made in understanding the mechanisms contributing to the pathogenesis of renal fibrosis, there are only a few therapies available to treat or prevent renal fibrosis in clinical use today. Therefore, identifying the key cellular and molecular mediators involved in the pathogenesis of renal fibrosis will provide new therapeutic strategy for treating patients with chronic kidney disease (CKD). β-Arrestin-1, a member of β-arrestin family, not only is a negative adaptor of G protein-coupled receptors (GPCRs), but also acts as a scaffold protein and regulates a diverse array of cellular functions independent of GPCR activation. In this study, we identified for the first time that β-arrestin-1 was upregulated in the kidney from mice with unilateral ureteral obstruction nephropathy as well as in the paraffin-embedded sections of human kidneys from the patients with diabetic nephropathy, polycystic kidney, or uronephrosis, which normally causes renal fibrosis. Deficiency of β-arrestin-1 in mice significantly alleviated renal fibrosis by the regulation of inflammatory responses, kidney fibroblast activation, and epithelial-mesenchymal transition (EMT) in both in vivo and in vitro studies. Furthermore, we found that among the major isoforms of Wnts, Wnt1 was regulated by β-arrestin-1 and gene silencing of Wnt1 inhibited the activation of β-catenin and suppressed β-arrestin-1-mediated renal fibrosis. Collectively, our results indicate that β-arrestin-1 is one of the critical components of signal transduction pathways in the development of renal fibrosis. Modulation of these pathways may be an innovative therapeutic strategy for treating patients with renal fibrosis.Key messagesβ-Arrestin-1 was upregulated in the kidney from mice with UUO nephropathy.β-Arrestin-1 regulated kidney fibroblast activation and epithelial-mesenchymal transition.β-Arrestin-1 exacerbated renal fibrosis via mediating Wnt1/β-catenin signaling.

Wnt/ -Catenin Signaling Promotes Renal Interstitial Fibrosis

Wnt/beta-catenin signaling promotes renal interstitial fibrosis.

A Role Of Wnt/Beta-Catenin Signaling In The Pathogenesis Of Renal Interstitial Fibrosis

[Crosstalk Between Canonical TGF-β/Smad and Wnt/β-catenin Signaling Pathway].

Targeting the Wnt/β-Catenin Signaling Pathway as a Potential Therapeutic Strategy in Renal Tubulointerstitial Fibrosis

FoxM1 Promotes Wnt/β‐catenin Pathway Activation and Renal Fibrosis Via Transcriptionally Regulating Multi‐wnts Expressions

MiR-155-5p Promotes Renal Interstitial Fibrosis in Obstructive Nephropathy Via Inhibiting SIRT1 Signaling Pathway

β-Arrestin-1 deficiency ameliorates renal interstitial fibrosis by blocking Wnt1/β-catenin signaling in mice

Targeted Inhibition of Β-Catenin/cbp Signaling Ameliorates Renal Interstitial Fibrosis

Renal Tubule Repair: Is Wnt/β-Catenin a Friend or Foe?

WNT1‐inducible signaling protein‐1 mediates TGF‐β1‐induced renal fibrosis in tubular epithelial cells and unilateral ureteral obstruction mouse models via autophagy

Mice Overexpressing Latent Tgf-Beta 1 Are Protected Against Renal Fibrosis In Obstructive Kidney Disease

Myeloid-derived Wnts play an indispensible role in macrophage and fibroblast activation and kidney fibrosis

Mice overexpressing latent TGF-β1 are protected against renal fibrosis in obstructive kidney disease

WNT–β-catenin signalling — a versatile player in kidney injury and repair

Signaling Mechanism of Renal Fibrosis in Unilateral Ureteral Obstructive Kidney Disease in Rock1 Knockout Mice

Defective CFTR Leads to Aberrant Β-Catenin Activation and Kidney Fibrosis

Developmental signalling pathways in renal fibrosis: the roles of Notch, Wnt and Hedgehog

Rictor/mTORC2 signaling mediates TGFβ1-induced fibroblast activation and kidney fibrosis

Epithelial and interstitial Notch1 activity contributes to the myofibroblastic phenotype and fibrosis

Aberrant Activity of Wnt/Frizzled Signaling Pathway in Renal Cancer Cell Lines